StockData
Actinium Pharmaceuticals, Inc. logo

Actinium Pharmaceuticals, Inc. (ATNM) stock

ATNMNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/3081% below fair value
$1.08−0.27 (-20.00%)

Close on Nov 18, 2026Market cap $33.96MP/E 3.0Yield –

Actinium Pharmaceuticals profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Actinium Pharmaceuticals's profit margin for the twelve months ending Dec 31, 2025 was -37652.2%. For fiscal 2025 it was -37652.2%, against -60269.1% the year before.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-37652.2%+22616.9
FY2023Dec 31, 2023-60269.1%−57063.6
FY2022Dec 31, 2022-3205.5%−1040.0
FY2021Dec 31, 2021-2165.6%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202679.7%+625.4
Q3 FY2025Sep 30, 2025-5701.1%+29125.0
Q3 FY2022Sep 30, 2022-21053.3%−18296.7
Q2 FY2022Jun 30, 2022-17260.0%−15372.4
Q1 FY2022Mar 31, 2022-545.6%+309.7
Q4 FY2021Dec 31, 2021-34826.1%–
Q3 FY2021Sep 30, 2021-2756.7%–
Q2 FY2021Jun 30, 2021-1887.6%–
Q1 FY2021Mar 31, 2021-855.3%–

More Actinium Pharmaceuticals figures

See a number that looks wrong?